EQUIMOXIN 18.92 mg/g oral gel for horses
Translucent clear to yellow oral gel with moxidectin
|type of preparative:||Antiparasitics|
|target species animals:||Horse|
1 gram of gel contains moxidectinum 18.92 mg
Translucent, clear to yellow oral gel.
Infestation with parasites hypersensitive to moxidectin:
Strongylus vulgaris (adults and arterial stages)
Strongylus edentatus (adults and visceral stages)
Triodontophorus brevicauda (adults)
Triodontophorus serratus (adults)
Triodontophorus tenuicollis (adults)
Small strongylidae (adults and intraluminal larval stages):
Parascaris equorum (adults and larval stages)
Oxyuris equi (adults and larval stages)
Habronema muscae (adults)
Gasterophilus intestinalis (L2, L3)
Gasterophilus nasalis (L2, L3)
Strongyloides westeri (adults)
The product induces a consistent efficacy against small strongylidae for a two-week period. Excretion of small strongylidae eggs is suppressed for 90 days. The product is effective against (developing) intramucosal stages (L4) of small strongylidae. Within 8 weeks after the treatment early (hypobiotic) L3 stages of small strongylidae are eliminated.
Not food-producing horses.
A single-dose oral administration. The recommended dose is 0.4 mg of moxidectin/kg per body weight which equals to 1.056 g of product/50 kg bw. One part of a piston scale on the applicator equals to the recommended dose of 50 kg per bw of a horse. The content of 1 applicator is intended for a horse weighing 700 kg of bw.
For accurate dosage it is recommended to determine the animal’s weight via a tape measure. The applicator needs to be adjusted to the calculated dose by setting the ring on the piston marker.
Do not use in horses whose meat or milk is intended for human consumption. The horse must be declared not for food production.
Special storage precautions
Keep out of the reach of children. Do not freeze. Store in the original package to protect the product from light.
Do not use after its expiry date stated on the label and the carton.
Use during pregnancy, lactation
The product can be used during pregnancy or lactation.
Special precautions for use in animals
Special precautions for use in animals
The product was developed specifically for horses only. Dogs and cats may present with adverse reactions after ingestion of moxidectin concentration contained in the product, e.g. after ingestion of a spilled gel or through contact with the applicator used. Protect animals from direct contact with the product. The following procedures should be avoided as they increase a risk of resistance and may ultimately result in an ineffective therapy:
- Frequent and repeated use of anthelmintic drugs of the same group, or a long period of drug administration
- Underdosing due to incorrect setting of bodyweight, incorrect use of the product or inadequate calibration of the dosing device.
Using appropriate tests (e.g. egg count reduction test – FECRT), suspected clinical cases of resistance to anthelmintic drugs should be assessed. When the test results confirm resistance to a specific anthelmintic drug, another anthelmintic drug of a different group having a different type of action should be used.
Special precautions for people administering the veterinary medicinal product to animals. The product may cause skin and eye irritation. Therefore avoid contact with skin or eyes. Personal protective equipment should be used when handling the veterinary medicinal product including protective gloves. If skin is affected, wash the affected area with water and soap. If eyes are affected, rinse them immediately with plenty of clean water. In case of irritation, seek medical help. In case of accidental ingestion, seek medical advice immediately and show this package leaflet or the label to your doctor. Do not eat, drink or smoke while handling the product.
1 x 14.8 g, 10 x 14.8 g.
Not all pack sizes may be marketed.